Salili, Janine .

HRN: 14-05-85  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/15/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/15/2022
08/22/2022
IV
375mg
Q8H
Amoebiasis
Waiting Final Action 
08/15/2022
CEFUROXIME 1.5GM (VIAL)
08/15/2022
08/22/2022
IV
750 Mg
Q8H
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: